Sector Chart Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 28/08/2026 am IST
|
5-day change | 1st Jan Change | ||
| 59.26 USD | -1.30% |
|
+4.87% | +34.53% |
| 22/08 | Scholar Rock's Global Regulatory Path Further De-Risked, Wedbush Says | MT |
| 21/08 | Wedbush Adjusts Scholar Rock Price Target to $64 From $58, Maintains Outperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 731.2Cr | - | - | - | - | - |
| 7.04TCr | |||||
| 6.54TCr | |||||
| 2.83TCr | - | ||||
| 2.66TCr | |||||
| 2.72TCr | - |
Select your edition
All financial news and data tailored to specific country editions
